Teva Pharmaceutical Industries (TEVA) Net Income Growth (5y) (2014 - 2026)
Teva Pharmaceutical Industries (TEVA) Net Income Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.17% |
| Dec 31, 2025 | 24.36% |
| Sep 30, 2025 | 15.96% |
| Jun 30, 2025 | 39.60% |
| Mar 31, 2025 | 53.28% |
| Dec 31, 2024 | -40.31% |
| Sep 30, 2024 | -5.34% |
| Jun 30, 2024 | -5.48% |
| Mar 31, 2024 | 49.95% |
| Dec 31, 2023 | 11.17% |
| Sep 30, 2023 | 19.20% |
| Jun 30, 2023 | -39.13% |
| Mar 31, 2023 | -17.18% |
| Dec 31, 2022 | 35.27% |
| Sep 30, 2022 | -36.36% |
| Jun 30, 2022 | 45.82% |
| Mar 31, 2022 | -28.73% |
| Dec 31, 2021 | 11.55% |
| Sep 30, 2021 | -5.59% |
| Jun 30, 2021 | -1.54% |